Skip to main content

Dysport Side Effects

Generic name: abobotulinumtoxinA

Medically reviewed by Drugs.com. Last updated on Jan 14, 2024.

Note: This document contains side effect information about abobotulinumtoxinA. Some dosage forms listed on this page may not apply to the brand name Dysport.

Applies to abobotulinumtoxinA: intramuscular powder for solution.

Warning

Intramuscular route (Powder for Solution)

The effects of abobotulinumtoxinA and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults, particularly in those patients who have underlying conditions that would predispose them to these symptoms.

Serious side effects of Dysport

Along with its needed effects, abobotulinumtoxinA (the active ingredient contained in Dysport) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking abobotulinumtoxinA:

More common

Less common

Incidence not known

Other side effects of Dysport

Some side effects of abobotulinumtoxinA may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to abobotulinumtoxinA: injectable powder for injection, intramuscular powder for injection.

General

The most commonly occurring side effects have included muscular weakness, dysphagia, dry mouth, injection site pain and discomfort, fatigue, headache, and nasopharyngitis.

Nervous system

Very common (10% or more): Dysphonia (up to 28%), headache (11%), facial paresis (up to 11%)

Common (1% to 10%): Dizziness, convulsion, syncope, hypoesthesia, partial seizures[Ref]

Cardiovascular

Common (1% to 10%): Hypertension, peripheral edema[Ref]

Gastrointestinal

Very common (10% or more): Dysphagia (up to 39%), dry mouth (up to 39%)

Common (1% to 10%): Nausea, diarrhea, constipation, vomiting, gastroenteritis[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection, blood present in urine[Ref]

Hepatic

Uncommon (0.1% to 1%): Abnormal liver function tests[Ref]

Hypersensitivity

Rare (less than 0.1%): Anaphylaxis, urticaria, soft tissue edema

Postmarketing reports: Hypersensitivity reactions including anaphylaxis[Ref]

Metabolic

Frequency not reported: Blood triglycerides increased[Ref]

Ocular

Very common (10% or more): Eye disorders (e.g., vision blurred, diplopia, visual acuity reduced, eye pain, eyelid disorder, accommodation disorder, dry eye, eye pruritus) (up to 17%)

Common (1% to 10%): Eyelid edema, eyelid ptosis

Postmarketing reports: Photophobia[Ref]

Local

Very common (10% or more): Injection site discomfort (e.g., pain, bruising, hemorrhage, injection site erythema/hematoma) (up to 22%)

Common (1% to 10%): Injection site pain[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis (10%), upper respiratory infection (10%)

Common (1% to 10%): Breathing difficulty, dyspnea, sinusitis, cough, pharyngitis, bronchitis, rhinitis, oropharyngeal pain[Ref]

Musculoskeletal

Very common (10% or more): Muscular weakness (up to 56%)

Common (1% to 10%): Musculoskeletal pain, muscle atrophy, pain in extremity, back pain, wrist fracture

Uncommon (0.1% to 1%): Gait disturbance, hypertonia

Postmarketing reports: Amyotrophy[Ref]

Immunologic

Common (1% to 10%): Infection, influenza, neutralizing antibodies[Ref]

Dermatologic

Frequency not reported: Excessive granulation tissue, erythema[Ref]

Other

Very common (10% or more): Fatigue (12%)

Common (1% to 10%): Fall, injury, contusion, ear infection, pyrexia

Uncommon (0.1% to 1%): Sensation of heaviness

Frequency not reported: Distant spread of toxin effects

Postmarketing reports: Vertigo, burning sensation, hypoesthesia

Psychiatric

Common (1% to 10%): Depression, insomnia[Ref]

Frequently asked questions

References

1. Product Information. Dysport (abobotulinumtoxinA). Tercica Inc. PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.